Unstable Angina Clinical Trial
— DEMONSTRATEOfficial title:
Randomized Comparison Between a DES and a BMS to Assess Neointimal Coverage by OCT Evaluation
NCT number | NCT01543373 |
Other study ID # | C21101 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2012 |
Est. completion date | April 2014 |
Verified date | April 2018 |
Source | CID - Carbostent & Implantable Devices |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to demonstrate the non-inferiority of Cre8 (CID) Drug Eluting Stent, studied 3 months after implant, compared to Vision/Multilink8 Bare Metal Stent (Abbott) studied at 1 month, in terms of neointimal coverage, determined by Optical Coherence Tomography (OCT), as percentage of cross-sections with RUTTS (Ratio of Uncovered to Total Stent Struts Per Cross Section) score ≤ 0.3.
Status | Completed |
Enrollment | 38 |
Est. completion date | April 2014 |
Est. primary completion date | August 2013 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age > 18 years; - Patients with symptoms of stable or unstable angina and/or presence of a positive functional test for ischemia; - Patient is eligible for percutaneous coronary intervention (PCI) and is an acceptable candidate for surgical revascularization (CABG); - Left ventricular ejection fraction > 30%; - Patients presenting with at least two vessels disease requiring a staged procedure within 3 months, according to the operator judgement; - Target de-novo lesion; - Target lesion located in a target vessel with a diameter ranging from 2.5 to 3.75 mm; - Target lesion diameter stenosis > 50% and < 100% by visual estimate, with a TIMI flow of >=1; - Discrete lesion with a length ranging from 13 to 25 mm; - The target lesion must be appropriately covered (margin of 2.5 mm on both sides of the stent) by one study stent (Cre8 or Vision/Multilink 8), according to the randomization arm; - Patient has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as approved by the Ethical Committee of the respective clinical site. Exclusion Criteria: - Female with childbearing potential or lactating; - Patient presenting with acute myocardial infarction with ST elevation; - Known allergies to antiplatelets, anticoagulants, contrast media, sirolimus or cobalt chromium; - Cerebrovascular accident within the past 6 months; - Acute or chronic renal dysfunction (defined as creatinine greater than 2.0 mg/dl); - Thrombocytopenia (platelet count less than 100,000/mm³); - Known bleeding or hypercoagulable disorder; - Currently under immunosuppressant therapy; - Co-morbidities that could interfere with completion of study procedures, or life expectancy less than 1 year; - Participating in another investigational drug or device trial that has not completed the primary endpoint or would interfere with the endpoints of this study; - Patient underwent target vessel revascularization with a DES; - Heavily calcified vessel and/or lesion which cannot be successfully predilated or imaged by OCT - Target lesion is located or supplied by an arterial or venous bypass graft; - Lesion located very distally, difficult to be imaged by OCT; - Lesion located in angulated (>70°), sharp take-off vessel; - Target lesion involving a bifurcation with a side branch =2.0 mm in diameter; - Target lesion located in the left main stem; - Ostial lesion location; - Target lesion has TIMI 0 flow; - Target vessel with angiographically visible thrombus or unsuitable for proper stent delivery and deployment. |
Country | Name | City | State |
---|---|---|---|
Italy | ULSS n°3 - Ospedale Civile | Bassano del Grappa | VI |
Italy | Azienda Ospedaliero - Universitaria S.Anna | Ferrara | FE |
Italy | Azienda Ospedaliera S. Giovanni - Addolorata | Roma | RM |
Italy | Policlinico Universitario "Agostino Gemelli" | Roma | RM |
Italy | Presidio Ospedaliero Umberto I - Azienda Ospedaliera "Ordine Mauriziano di Torino" | Torino | TO |
Netherlands | University Medical Centre Utrecht | Utrecht |
Lead Sponsor | Collaborator |
---|---|
CID - Carbostent & Implantable Devices |
Italy, Netherlands,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ratio of Uncovered to Total Stent Struts Per Cross Section (RUTTS) score of = 0.3, determined by OCT | 1 month for the BMS arm; 3 months for the DES arm | within 3 months from index procedure | |
Secondary | Percentage of malapposed stent struts | Immediately post index procedure, 1 month (BMS arm) / 3 months (DES arm) | ||
Secondary | Percentage of malapposed and uncovered stent struts | 1 month (BMS arm) / 3 months (DES arm) | ||
Secondary | Neointimal growth and neointimal thickness | 1 month (BMS arm) / 3 months (DES arm) | ||
Secondary | Angiographic in-stent and in-segment endpoints | reference vessel diameter; minimal lumen diameter; % diameter stenosis; binary restenosis; late lumen loss | immediately pre and post index procedure, 1 month (BMS arm) / 3 months (DES arm) | |
Secondary | Clinical composite endpoints | Cardiac death/Target vessel MI/Clinically indicated TLR All death/All MI/All TVR (including TLR) |
At 1, 3 and 12 months | |
Secondary | Stent Thrombosis | during index procedure, immediately after index procedure, 1 month, 3 months, 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
Not yet recruiting |
NCT03610529 -
CardioSenseSystem Compared Study Regarding Efficacy and Safety in the Monitoring of ECG
|
N/A | |
Withdrawn |
NCT03906812 -
A Randomized Trial of Telemetry Compared With Unmonitored Floor Admissions in ED Patients With Low-Risk Chest Pain
|
N/A | |
Completed |
NCT01826552 -
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
|
Phase 4 | |
Completed |
NCT01709669 -
The Impact of Gratitude on Biology and Behavior in Persons With Heart Disease
|
N/A | |
Completed |
NCT01688648 -
Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft
|
N/A | |
Completed |
NCT01171404 -
Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge
|
N/A | |
Completed |
NCT01020383 -
Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
|
Phase 2 | |
Completed |
NCT01167582 -
Myocardial Ischemia and Transfusion Pilot
|
Phase 3 | |
Completed |
NCT00449826 -
Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)
|
N/A | |
Terminated |
NCT00355992 -
The Ischemia Modified Albumin In Diagnosing Ischemic New Events
|
N/A | |
Completed |
NCT00263263 -
RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.
|
Phase 2 | |
Recruiting |
NCT04929496 -
Physiology as Guidance to Evaluate the Direct Impact of Coronary Lesion Treatment: The PREDICT Study
|
N/A | |
Completed |
NCT03103620 -
Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
|
||
Completed |
NCT04648306 -
Restore EF Observational Study
|
||
Not yet recruiting |
NCT03266289 -
Evaluation of Short Term Outcome of Different Bifurcation Stenting Techniques at Assuit University Cath. Lab
|
N/A | |
Not yet recruiting |
NCT04403048 -
Drug Coated Balloon for Side Branch Treatment vs. Conventional Approach in True Bifurcation Coronary Disease: PRO-DAVID
|
N/A | |
Recruiting |
NCT02748603 -
Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease
|
N/A | |
Completed |
NCT01774838 -
Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
|
Phase 3 |